A/P 25/45 (Alogliptin Benzoate and Pioglitazone Hydrochloride 25 mg / 45 mg)

Pill with imprint A/P 25/45 is Red, Round and has been identified as Alogliptin Benzoate and Pioglitazone Hydrochloride 25 mg / 45 mg. It is supplied by Perrigo New York Inc..

Alogliptin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Alogliptin/pioglitazone 25 mg / 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A/P 25/45

Alogliptin Benzoate and Pioglitazone Hydrochloride

Imprint:

A/P 25/45

Strength:

25 mg / 45 mg

Color:

Red

Shape:

Round

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Perrigo New York Inc.

National Drug Code (NDC):

45802-0499

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer